C07K 16/12
Against material from bacteria
Official title: against material from bacteria
C07K16/12 (Against material from bacteria) appears on 2,455 US grants and 3,074 published applications in this corpus.
Search patents in C07K- Granted patents
- 2,455
- Published applications
- 3,074
- Assignees
- 1,331
- Inventors
- 5,117
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 9 | 0 |
| 1985 | 5 | 0 |
| 1986 | 5 | 0 |
| 1987 | 11 | 0 |
| 1988 | 14 | 0 |
| 1989 | 12 | 0 |
| 1990 | 15 | 0 |
| 1991 | 17 | 0 |
| 1992 | 20 | 0 |
| 1993 | 28 | 0 |
| 1994 | 17 | 0 |
| 1995 | 14 | 0 |
| 1996 | 33 | 0 |
| 1997 | 46 | 0 |
| 1998 | 62 | 0 |
| 1999 | 52 | 0 |
| 2000 | 50 | 0 |
| 2001 | 52 | 10 |
| 2002 | 43 | 67 |
| 2003 | 52 | 105 |
| 2004 | 42 | 108 |
| 2005 | 36 | 86 |
| 2006 | 47 | 84 |
| 2007 | 54 | 95 |
| 2008 | 48 | 88 |
| 2009 | 57 | 107 |
| 2010 | 67 | 127 |
| 2011 | 78 | 153 |
| 2012 | 81 | 146 |
| 2013 | 106 | 145 |
| 2014 | 119 | 170 |
| 2015 | 102 | 175 |
| 2016 | 139 | 201 |
| 2017 | 127 | 157 |
| 2018 | 132 | 152 |
| 2019 | 113 | 142 |
| 2020 | 113 | 140 |
| 2021 | 99 | 130 |
| 2022 | 73 | 107 |
| 2023 | 67 | 109 |
| 2024 | 71 | 127 |
| 2025 | 72 | 85 |
| 2026 | 39 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- RNA encoding an antibody29 Sep 2026US 12,747,451 B2Cure Vac SE
- Antibody specifically binding to strep-tag II tag and use thereof1 Sep 2026US 12,723,070 B2Beijing Yimiaoyiliao Co., Ltd
- Clostridium difficile antigens25 Aug 2026US 12,714,742 B2MicroPharm Limited
- Rifamycin analogs and antibody-drug conjugates thereof25 Aug 2026US 12,715,881 B2Regeneron Pharmaceuticals, Inc.
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
- Red Light-Controlled Protein Dimerization Systems24 Sep 2026US 2026/0285953 A1University of Washington
- Antibodies17 Sep 2026US 2026/0273037 A1Hydrosense Ltd
- Anti-etec adhesin protein antibodies and methods of use17 Sep 2026US 2026/0274929 A1University of Massachusetts
Most cited
By later US patents
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Human antibodies derived from immunized xenomice1,057US 6,075,181 AAbgenix, Inc. · 2000
- Human antibodies derived from immunized xenomice943US 6,150,584 AAbgenix, Inc. · 2000
- Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme640US 9,371,394 B2Dow AgroSciences LLC · 2016
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000